APA (7th ed.) Citation

RM, H., CD, M., K, N., C, C., TM, W., RL, K., . . . SH, K. (2021). Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance. NAR cancer, 3(3), zcab028. https://doi.org/10.1093/narcan/zcab028

Chicago Style (17th ed.) Citation

RM, Hurley, et al. "Characterization of a RAD51C-silenced High-grade Serous Ovarian Cancer Model During Development of PARP Inhibitor Resistance." NAR Cancer 3, no. 3 (2021): zcab028. https://doi.org/10.1093/narcan/zcab028.

MLA (9th ed.) Citation

RM, Hurley, et al. "Characterization of a RAD51C-silenced High-grade Serous Ovarian Cancer Model During Development of PARP Inhibitor Resistance." NAR Cancer, vol. 3, no. 3, 2021, p. zcab028, https://doi.org/10.1093/narcan/zcab028.